Yaping Zhang on Platelet Adhesion Receptors
Yaping Zhang, Postdoc Associate at University of Illinois Chicago, shared on LinkedIn:
”Glad to participate in publishing the chapter “Platelet Adhesion Receptors” in the book Platelet Physiology I.
Andrew Mack, Yaping Zhang & Xiaoping Du
Platelet adhesion receptors are essential for platelet attachment, aggregation, and activation, which are critical for normal hemostasis and pathological thrombosis.
These receptors regulate where and how platelets adhere, influencing thrombus size and stability, and they trigger signaling pathways that coordinate with other adhesion and activation receptors to promote platelet spreading, secretion, clot retraction, and thrombus formation.
Platelets use several major receptor families—including integrins, LRR receptors such as GPIb-IX-V, immunoglobulin superfamily receptors like GPVI, and C-type lectins—to bind ligands such as collagen, von Willebrand factor, fibrinogen, and laminin, enabling interactions with vessel walls, other platelets, leukocytes, microbes, and tumor cells.
Because adhesion is central not only to hemostasis and thrombosis but also to inflammation and immune responses, targeting these receptors and their signaling pathways remains a key strategy for developing antithrombotic therapies.”
Read the chapter here.
Article: Platelet Adhesion Receptors
Authors: Andrew Mack, Yaping Zhang, Xiaoping Du
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025